Journal article icon

Journal article

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Abstract:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has undergone progressive change, with variants conferring advantage rapidly becoming dominant lineages, e.g., B.1.617. With apparent increased transmissibility, variant B.1.617.2 has contributed to the current wave of infection ravaging the Indian subcontinent and has been designated a variant of concern in the United Kingdom. Here we study the ability of monoclonal antibodies and convalescent and vaccine sera to neutralize B.1.617...

Expand abstract
Publication status:
Published

Actions


Access Document


Files:
Publisher copy:
10.1016/j.cell.2021.06.020

Authors


Expand authors...
Wellcome Trust More from this funder
Publisher:
Elsevier Publisher's website
Journal:
Cell Journal website
Volume:
184
Issue:
16
Pages:
4220–4236
Publication date:
2021-06-16
Acceptance date:
2021-06-11
DOI:
EISSN:
1097-4172
ISSN:
0092-8674
Pmid:
34242578
Language:
English
Keywords:
Pubs id:
1185792
Local pid:
pubs:1185792
Deposit date:
2021-08-16

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP